Drug intelligence / Profile preview

allogenic lyophilized growth factors

Development stage
Phase 2
Modality
Other Cell Types → Cell Therapies, Recombinant Proteins and Enzymes, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intraarticular, Intralesional, Topical
01

Overview

Allogenic lyophilized growth factors are a biologic product derived from pathogen-free donor (allogeneic) human platelets. Unlike traditional platelet-rich plasma (PRP), which uses autologous (self-donated) blood, this formulation utilizes standardized numbers of allogenic platelets that are processed and then freeze-dried (lyophilized) to preserve their bioactive components. The resulting product contains a concentrated mix of key regenerative and immunomodulatory proteins—primarily various growth factors such as platelet-derived growth factor, transforming growth factor-beta, fibroblast growth factor, endothelial cell growth factor, connective tissue growth factor, vascular endothelial cell growth factor, and hepatocyte growth factor. These molecules stimulate epithelial cells and fibroblasts to promote new collagen and elastin formation as well as tissue repair[2][3][4][8]. The main clinical applications studied include musculoskeletal disorders such as knee osteoarthritis[1][7], subacromial impingement syndrome[2][6], plantar fasciitis[2], and chronic ulcers[8]. The mechanism is based on enhancing local tissue regeneration by delivering exogenous human platelet-derived signaling molecules in a controlled manner.

Other names
lyophilized growth factorsL-GFallogeneic lyophilized growth factorsplatelet-derived lyophilized growth factors
02

Targets

PDGFRA (Platelet-derived growth factor receptor alpha)TGFBR2 (TGF-β receptor type 2)VEGFR2 (Vascular endothelial growth factor receptor 2)

Beyond the preview

Go deeper on allogenic lyophilized growth factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogenic lyophilized growth factors.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call